{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:43:00Z","timestamp":1793882580340,"version":"4.7.0"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>This is a single-center, retrospective, cohort study aimed to evaluate the clinical outcomes of multi-drug resistance in Acinetobacter baumannii infections (MDR-AB) in intensive care unit (ICU) patients with or without a COVID-19 infection and risk factors for blood stream infection. A total of 170 patients with MDR-AB were enrolled in the study. Of these, 118 (70%) patients were admitted to the ICU due to a COVID-19 infection. Comparing the COVID-19 and non-COVID-19 groups, the use of mechanical ventilation (98.31% vs. 76.92%, p = 0.000), the presence of septic shock (96.61% vs. 82.69%, p = 0.002), and the use of steroid (99.15% vs. 71.15%, p = 0.000) and tocilizumab therapies (33.05% vs. 0%, p = 0.000) were more prevalent and statistically more significant in patients with COVID-19 infections. The average length of the ICU stay (21.2 vs. 28.33, p = 0.0042) was significantly lower in patients with COVID-19 infections. Survival rate was 21.19% for the COVID-19 group and 28.85% for non-COVID-19 group with a p-value = 0.0361. COVID-19 status was associated with significantly higher hazards of death (HR 1.79, CI 95% 1.02\u20133.15, p = 0.043). Higher SOFAB (15.07 vs. 12.07, p = 0.0032) and the placement of an intravascular device (97.06% vs. 89.71%, p = 0.046) were significantly associated with the development of a bloodstream infection. Our study has shown that critically ill patients with an MDR-AB infection, who were admitted due to a COVID-19 infection, had a higher hazard for death compared to non-COVID-19 infected patients.<\/jats:p>","DOI":"10.3390\/healthcare11040487","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T03:57:16Z","timestamp":1675828636000},"page":"487","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection"],"prefix":"10.3390","volume":"11","author":[{"given":"Thamer A.","family":"Alenazi","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, King Fahad Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam S. Bin","family":"Shaman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Prince Mohammad Medical City, Ministry of Health, Aljouf 85846, Saudi Arabia"},{"name":"Department of Pharmaceutical Care, King Fahd Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durria M.","family":"Suliman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, King Fahad Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turkiah A.","family":"Alanazi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, King Fahd Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoroq M.","family":"Altawalbeh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 566, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-7229","authenticated-orcid":false,"given":"Hanan","family":"Alshareef","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doha I.","family":"Lahreche","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, King Fahad Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayer","family":"Al-Azzam","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 566, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-8585","authenticated-orcid":false,"given":"Mohammad","family":"Araydah","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, P.O. Box 566, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2919-1280","authenticated-orcid":false,"given":"Reema","family":"Karasneh","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, P.O. Box 566, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faycal","family":"Rebahi","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, King Fahad Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah H.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Radiology Department, King Fahad Specialist Hospital, Ministry of Health, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-7612","authenticated-orcid":false,"given":"Mamoon A.","family":"Aldeyab","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into Acinetobacter baumannii: Pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities","volume":"11","author":"Asif","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1128\/JCM.36.7.1938-1941.1998","article-title":"Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates","volume":"36","author":"Jawad","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care\u2013associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijantimicag.2016.01.015","article-title":"Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii","volume":"47","author":"Lob","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00310-16","DOI":"10.1128\/mSphere.00310-16","article-title":"Global assessment of the activity of tigecycline against multidrug-resistant Gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial","volume":"2","author":"Giammanco","year":"2017","journal-title":"Msphere"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhin.2011.08.013","article-title":"Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces","volume":"80","author":"Espinal","year":"2012","journal-title":"J. Hosp. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MCC.0000000000000534","article-title":"Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant\/extensively drug-resistant\/pandrug-resistant bacteria","volume":"24","author":"Bassetti","year":"2018","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e02562-17","DOI":"10.1128\/AAC.02562-17","article-title":"Comparison of septic shock due to multidrug-resistant Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit patients","volume":"62","author":"Russo","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_10","unstructured":"(2022, September 27). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available online: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/who-china-joint-mission-on-covid-19-final-report.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2020.10.022","article-title":"Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: A scoping review","volume":"Volume 96","author":"Huang","year":"2021","journal-title":"Proceedings of the Mayo Clinic Proceedings"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: A clinical\u2013therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jmv.26429","article-title":"Late onset infectious complications and safety of tocilizumab in the management of COVID-19","volume":"93","author":"Pettit","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","article-title":"Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?","volume":"53","author":"Lai","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-020-00736-x","article-title":"Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU","volume":"10","author":"Contou","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"ref_18","first-page":"158","article-title":"Infecci\u00f3n bacteriana\/f\u00fangica en pacientes con COVID-19 ingresados en un hospital de tercer nivel de Castilla y Le\u00f3n, Espa\u00f1a","volume":"40","year":"2020","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104806","DOI":"10.1016\/j.micinf.2021.104806","article-title":"Bacterial and fungal co-infections among COVID-19 patients in intensive care unit","volume":"23","author":"Yang","year":"2021","journal-title":"Microbes Infect."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cultrera, R., Barozzi, A., Libanore, M., Marangoni, E., Pora, R., Quarta, B., Spadaro, S., Ragazzi, R., Marra, A., and Segala, D. (2021). Co-infections in critically ill patients with or without COVID-19: A comparison of clinical microbial culture findings. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18084358"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s15010-021-01643-4","article-title":"Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit","volume":"50","author":"Russo","year":"2022","journal-title":"Infection"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcrc.2021.08.010","article-title":"Incidence, outcomes, and predictors of Acinetobacter infection in Saudi Arabian critical care units","volume":"66","author":"Kharaba","year":"2021","journal-title":"J. Crit. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-018-0301-x","article-title":"Prevalence of Acinetobacter baumannii in Saudi Arabia: Risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance Annals of Clinical Microbiology and Antimicrobials","volume":"18","author":"Ibrahim","year":"2019","journal-title":"Ibrahim. Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of Acinetobacter infections: A century of challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: Emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Alqahtani, A., Alamer, E., Mir, M., Alasmari, A., Alshahrani, M.M., Asiri, M., Ahmad, I., Alhazmi, A., and Algaissi, A. (2022). Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19042424"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.infpip.2021.100113","article-title":"An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital","volume":"3","author":"Gottesman","year":"2021","journal-title":"Infect. Prev. Pract."},{"key":"ref_30","first-page":"250","article-title":"A Comparative Study of Acinetobacter Infections in COVID and Non-COVID Patients","volume":"8","author":"Syed","year":"2022","journal-title":"J. Infect. Dis. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.26237","article-title":"Obesity aggravates COVID-19: A systematic review and meta-analysis","volume":"93","author":"Yang","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107102","DOI":"10.1016\/j.intimp.2020.107102","article-title":"Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial","volume":"89","author":"Malekzadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jmv.26016","article-title":"Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia","volume":"93","author":"Mazzitelli","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100410","DOI":"10.1016\/j.eclinm.2020.100410","article-title":"Subcutaneous tocilizumab treatment in patients with severe COVID-19\u2013related cytokine release syndrome: An observational cohort study","volume":"24","author":"Mastroianni","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref_38","unstructured":"(2022, October 15). Saudi MoH Protocol for Patients Suspected of\/Confirmed with COVID-19, Available online: https:\/\/www.moh.gov.sa\/Ministry\/MediaCenter\/Publications\/Documents\/MOH-therapeutic-protocol-for-COVID-19.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America Guidance on the Treatment of AmpC \u03b2-Lactamase\u2013Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin. Infect. Dis."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/4\/487\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:27:36Z","timestamp":1760120856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/4\/487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["healthcare11040487"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11040487","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}